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Abstract 
Ventilator-associated pneumonia (VAP) is a serious complication in critically ill patients; it can 
prolong intubation, increase intensive care unit and hospital length of stay, and increase mortality 
to twice the level of patients who do not develop VAP. The purpose of this project was to 
determine the effect of an evidence-based educational program to prevent VAP on ICU nurses’ 
actual and documented practices for preventing VAP. The research questions addressed whether 
an educational program focused on VAP prevention will affect critical care nurses’ compliance 
with a VAP prevention bundle, and whether the education will result in maintenance of a rate of 
zero cases of VAP per 1000 ventilator days. Data will be collected from all ICU patients 
intubated more than 24 hours and will include:  (a) the frequency of oral care, (b) head-of-bed 
elevation of 30–45 degrees, (c) daily sedation vacation, (d) assessment of readiness for 
extubation, and (e) whether prophylaxis for deep vein thrombosis and for peptic ulcer disease 
was ordered. Observations of care will verify the accuracy of nurses’ documentation in the 
medical record. A survey will assess nurse satisfaction with the educational program. Paired t 
tests will be used to compare the compliance of the nurses with each element of oral care and 
hygiene practices before and after the intervention. Analysis of variance will be calculated on the 
mean duration of ventilation, mean ICU and hospital length of stay, mortality before discharge, 
patient acuity, and rates of VAP per 1000 ventilator days. The goal of this project is a 
compliance rate of 90% or greater with the elements of the VAP prevention bundle, leading to 
decreased ventilator and ICU days, decreased morbidity, decreased mortality, and lower 
emotional distress. Positive social change will be accomplished through an immediate 
improvement in the lives of VAP-prone individuals.  
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 Section 1: Overview of the Evidence-Based Project 
Introduction 
Ventilator-associated pneumonia (VAP) is a preventable lung infection acquired in 
mechanically ventilated patients that was not present at the time of intubation (Centers for 
Medicare and Medicaid Services [CMS], 2013; Institute for Healthcare Improvement [IHI], 
2012). A serious complication in the intensive care unit, VAP prolongs intubation by 4-9 days 
compared to patients without VAP. Mortality attributable to VAP is reported at 25–50% (Efrati 
et al., 2010), double the mortality of patients without VAP (Safdar, Dezfulian, Collard, & Saint, 
2005).  
Due to extended hospital stays and increased morbidity and mortality, VAP is an 
expensive complication. A single VAP case can increase the cost of treatment by up to $25,000 
(CDC, 2009). The cost to treat VAP is not reimbursed by CMS, resulting in negative financial 
repercussions for hospitals which fail to effectively prevent VAP cases. Starting in January 2013, 
the CDC required that the precursors of VAP be reported, specifically ventilator-associated 
events (VAEs). Because they do not require radiographic or bacteriologic evidence of infection 
(CDC, 2013), the identification of cases is likely to increase.  
This paper proposes a project to strengthen the VAP/VAE prevention program in a 
community hospital by applying evidence-based practice guidelines. 
Problem Statement 
A number of strategies have been identified as effective in preventing VAP (Society for 
Healthcare Epidemiology of America/Infectious Diseases Society of America, SHEA/IDSA): 
limiting intubation time; preventing aspiration and airway contamination; reducing equipment 
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contamination; complying with hand hygiene; and training caregivers. Despite the available 
guidelines, knowledge of, and compliance with, the recommendations are not consistent among 
critical care nurses (Tolentino-DelosReyes, Ruppert, & Shiao, 2007), which places the patients at 
risk for harm and the facility at risk for financial loss. 
Purpose Statement and Project Objective 
The purpose of this project is to determine the effect of an evidence-based VAP 
educational program on actual and documented ICU nursing care practices for preventing VAP. 
The practices for this project derive from the “ventilator bundle” (VB) of interventions from the 
Institute for Healthcare Improvement (IHI, 2012). There are five VB practices: (a) Perform oral 
care with chlorhexidine gluconate oral rinse every 12 hours; (b) Maintain the head of the bed 
[HOB] elevation at 30-45 degrees; (c) Ensure a daily “sedation vacation” (a trial of decreased 
sedation to allow the patient to awaken and respond to commands) in order to assess patient 
readiness to be weaned from the ventilator; (d) Provide prophylaxis for deep vein thrombosis; 
and (e) Prophylaxis for peptic ulcer disease.  
A secondary purpose is to determine the effect of the educational program on the 
outcome of cases of VAP and VAEs. Although the IHI bundle (2012) addresses only VAP, 
VAEs are included in this project as an outcome because as of January 2013, they are reportable 
to CMS, and in the future may result in reduced payments to hospitals under pay-for-
performance computations.   
The objective of this project is to maintain a rate of zero cases of VAP and VAEs per 
1000 ventilator days. 
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Relevance to Practice 
Since the advent of VAP prevention bundles, there has been about a 45% reduction in 
cases of VAP (IHI, 2012). Due to successfully bundled interventions, many hospitals report more 
than a year without a VAP. Researchers also report decreased ventilator and ICU days 
(Dezfulian et al., 2005; Girard, et al., 2008; Kress, Pohlman, O'Connor, & Hall, 2000; Metheney, 
Davis-Jackson, & Stewart, 2010), reduced hospital length of stay (Kress et al, 2000; Metheny et 
al, 2010) and reduced mortality (Girard et al., 2008).  
With the implementation of simplified reporting criteria, previously unrecognized cases 
of VAP as well as VAEs will likely be identified. While this might have financial consequences, 
the ultimate goal of VAP prevention efforts is to reduce morbidity and mortality due to device-
related complications (Magill et al., 2013).  With decreased morbidity and mortality, the actual 
financial costs will be reduced.  
Project Questions 
The project questions are as follows:  
1. What is the effect of an educational program (VAP prevention guidelines, rationales, 
and strategies) focused on critical care nurses’ compliance with a VAP prevention bundle, as 
measured by care observed and documented in the medical record including (a) oral care with 
chlorhexidine per protocol, (b) elevation of the head of the bed to 30-45 degrees, (c) daily 
sedation vacations, and (d) assessment of readiness for extubation?  
2. Will the education yield a rate of zero cases of VAP and VAEs per 1000 ventilator 
days for the first 3 months after the educational intervention?  
3. What is the nurses’ level of satisfaction with the educational program?  
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4. Will there be a difference in the severity of illness, as measured by the APACHE II 
score, between intubated patients in the ICU before and after the educational intervention? 
Evidence-Based Significance of the Project 
Pneumonia acquired in a healthcare setting is a continuous concern for health agencies. 
CDC first published guidelines for the prevention of nosocomial pneumonia in 1981 and revised 
them in 1994 with recommendations for VAP. The original guidelines for managing pneumonia 
acquired in a health care setting were published in 1996 by the American Thoracic Society 
(ATS). The guidelines were revised in 2005 (ATS, 2005) in collaboration with the Infectious 
Disease Society of America (IDSA) and incorporated new research and VAP data. The revised 
guidelines addressed modifiable risk factors for VAP. The CDC updated its VAP guideline in 
2003 (CDC, 2003) using the 1996 ATS guidelines in their references.  CMS (2013) also 
published VAP prevention guidelines based on these older sources.  
As reported in Magill et al. (2013), a CDC-commissioned VAP surveillance definition 
working group recommended a new algorithm that considered a hierarchical classification of 
VAEs, ranging from ventilator-associated conditions (VACs), to infection-related ventilator-
associated complications (IVACs), then possible VAP, and probable VAP. The recommended 
changes were incorporated by the CDC in its protocol clarification document (CDC, 2013) and 
apply only to patients in adult ICU settings. (The pediatric population will continue to be 
monitored under the older definitions.) In its update of the practice recommendations for 
prevention of VAP, the Society for Healthcare Epidemiology of America (SHEA, 2014) 
recognized that VAEs prolong a patient’s duration of mechanical ventilation, length of stay in 
ICU and the hospital, and increase mortality, as does VAP. Under the new guidelines, to qualify 
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as a VAC, patients must display worsening oxygenation or the need for increased positive end-
expiratory pressure (PEEP) after 2 days of stable or decreasing oxygen needs. For IVAC, the 
criteria for VAC must be met in addition to a fever or increased white blood cell (WBC) count 
and prescribing of a new antibiotic that continues for 4 days or more. For possible VAP, the 
patients must meet criteria for VAC and IVAC plus have purulent respiratory secretions or 
positive respiratory cultures. For probable VAP, criteria are the same as for possible VAP except 
both purulent secretions and positive cultures must be present, or, with or without purulent 
secretions, a positive pleural culture or viral culture of respiratory secretions must be present 
(CDC, 2013, p. 15).  
One important justification for the revisions in the reporting measures is to objectify the 
criteria to prevent subjectivity in the reporting system, because decreased reported VAP rates or 
those near zero are not consistent with data from epidemiologic studies (CDC, 2013).  The data 
to identify VAC and IVAC cases is objective and can be collected from all ventilator patients 
(Mietto, Pinciroli, Patel, & Berra, 2013). VAC and IVAC criteria do not include radiographic 
evidence of new or worsening infiltrates, nor the collection, processing, and interpretation of 
respiratory cultures as is the case for VAP, both of which are subject to interpretation bias 
(Magill, et al., 2013). Accordingly, only VAC and IVAC are being considered for reporting and 
pay-for-performance purposes (CDC, 2013). Possible and probable VAP cases, while they will 
continue to be included in surveillance reports, are intended to contribute to internal quality 
control efforts. The simplified criteria are intended to increase the likelihood of identifying 
ventilator-associated complications, which increase the costs for health care agencies. 
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Implications for Positive Social Change 
The Institute of Medicine (IOM) in 2001 advanced an agenda to improve health care 
quality, including safe and effective care. In 2008, the U.S. Department of Health and Human 
Services set an agenda to guide public health practices for health systems, including a mandate to 
reduce risk for preventable harm, as well as utilize the best practices based on evidence. The 
proposed intervention is consistent with these agendas to develop effective strategies with high-
level evidence to mitigate the risk for harm in vulnerable populations. The social impact of 
robust intervention is specific to advancing public health, improved patient outcomes and 
decreased financial risk. 
This project is intended to provide ICU nurses with the ability to make evidence-based 
care decisions, and to practice in compliance with the VAP bundle. Ethics plays an important 
role in this project, since its focus is to avoid preventable complications for critically ill patients 
that can result in increased morbidity, mortality and cost (Scott, 2009), as well as emotional 
distress (Health.gov, 2014). In particular, the ethical tenet of beneficence or do no harm (Grove, 
Burns & Gray, 2013) is pertinent when there are strategies to prevent patient harm but these are 
not effectively implemented. Clinicians have an ethical responsibility to provide evidence-based 
care aimed to improve patient outcomes and to reduce patient risk for harm. Clinicians are remiss 
their duties if they fail to employ protocols such as the VAP bundle. 
Definitions of Terms 
The following operational definitions will be used for this improvement project: 
Ventilator-associated pneumonia (VAP): VAP is the presence of purulent respiratory 
secretions along with a positive culture of these secretions or of lung tissue; or in the absence of 
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purulent secretions, a positive pleural culture, positive lung histopathology, positive Legionella 
test, or positive test for one of several viruses, such as influenza, in respiratory secretions, 
occurring on or after Day 3 of mechanical ventilation or 2 days before or after the onset of 
worsening oxygenation (see below)  (CDC, 2013).  
Ventilator-associated event (VAE): VAE is a worsening of oxygenation for 2 days after 2 
days of stabilization or improvement as evidenced by increasing FiO2 requirements of 0.20 or 
PEEP >3 cm/H20 above the level noted in the stabilization period. These can be further 
classified as a ventilator-associated condition (VAC), infection-related ventilator-associated 
complication (IVAC), possible VAP, and probable VAP (CDC, 2013). See Appendix A for the 
complete algorithm as defined by the CDC. 
VAP prevention bundle: A group of activities, when consistently performed together, that 
help to prevent VAP and improve outcomes for patients. These include oral care using 
chlorhexidine gluconate 0.12% oral rinse; maintaining the head-of-bed at 30-45 degrees; daily 
sedation vacation and daily assessment of readiness to extubate; peptic ulcer disease prophylaxis; 
and deep vein thrombosis prophylaxis (IHI, 2012). 
Oral care protocol: The protocol is a set of prescribed activities for performance of oral 
care in ventilated patients according to a written policy and procedure developed in conjunction 
with this project (Appendix B). This policy is currently approved for implementation by the 
institution’s nursing director. 
Head-of-bed elevation: The measurement in degrees of the elevation of the backrest of 
the hospital bed according to a gauge built into the bed defines the head-of-bed elevation.  
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Sedation vacation: A temporary stoppage of continuous sedative infusion to allow the 
patient to awaken sufficiently to open eyes on command, follow the examiner with the eyes, or 
follow a command to squeeze a hand or protrude the tongue (Kress, Pohlman, O'Connor, & Hall, 
2000).  
Assumptions  
This study was based on the following assumptions: 
1. Nurses will perform the care that they document, and they will document all the care 
that they provide. 
2. Cases of VAE and VAP, as well as the number of ventilator days, will be accurately 
identified and reported. 
3. ICU nurses benefit from educational programs, enabling them to consistently 
implement the ventilator bundle. 
Limitations 
This study was subject to the following limitations: 
1. Nurses may alter their practices based on the presence of an observer, and therefore 
what the observer sees may not reflect what a nurse normally does. 
2. The facility implemented an electronic medical record (EMR) one year ago. This 
change represents a significant change in the documentation process, as well as the 
initiation of computerized physician order entry. Nurses will need instruction on 
where and how to properly document the practices of the VAP bundle. In addition, 
physicians entering orders for ventilated patients will need to be directed to the 
correct computerized order set within the EMR system. 
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Summary 
VAP is a preventable patient complication resulting from poor patient care practices in 
intubation and mechanical ventilation. It causes harm to patients, including death, and increases 
the cost of care (Efrati et al., 2010). To prevent the complication, nurses must understand and 
implement recommended strategies. An educational program was designed to address the 
knowledge deficit and to provide a coherent rationale for the change in practice. 
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 Section 2: Review of Scholarly Evidence 
Introduction 
The purpose of this project is to determine the effect of an evidence-based VAP 
educational program on actual and documented ICU nursing care practices for preventing VAP. 
There is a well-established body of research supporting an array of strategies for VAP 
prevention. Several of these could be used in this project. They relate to the precept that these 
events are caused by aspiration of oropharyngeal secretions that are contaminated with pathogens 
(Tablan, Anderson, Besser, Bridges, & Hajjeh, 2004), for which the removal or neutralization is 
helpful. Other strategies are aimed at the minimizing the duration of mechanical ventilation and 
intubation, given that the risk for VAP remains as long as the mechanical ventilation continues. 
In fact, the definition of VAP becomes applicable only after the patient experiences a worsening 
of her or his respiratory status for 2 days after having been stable or improving for 2 days; this 
means that the patient must be intubated for a minimum of 4 days before VAP can be diagnosed 
(CDC, 2013). In addition, general measures for infection prevention, such as hand hygiene, and 
optimizing care of the ventilated patient, have been shown to be beneficial in VAP prevention. 
This section will review the literature on each component of the recommended prevention 
strategies: The VAP bundle; hand hygiene; oral care; HOB elevation; subglottic secretion 
removal; and limiting the duration of mechanical ventilation. 
Literature Search Strategy 
The literature search consisted of searches of the following databases: Cinahl, Medline, 
Cochrane Database of Systematic Reviews, the Joanna Briggs Institute of EBP Database, as well 
as government sources such as the CDC and CMS websites. It also included foundational and 
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seminal sources 1985 to the present, and current peer-reviewed literature from 2010-2015. The 
following search terms were used: Ventilator-associated pneumonia, VAP, VAP bundle, oral 
care, hospital-acquired infection, prevention, and nosocomial. 
VAP Bundle 
The most current guidelines for VAP prevention focus on the components of the 
“ventilator bundle,” a group of interventions supported by research to decrease the rates of VAP 
and other complications common in ventilated patients (IHI, 2012). Two elements of the bundle 
are not intended to actually prevent VAP but to improve the overall care of the ventilated patient, 
namely deep vein thrombosis (DVT) prophylaxis and peptic ulcer disease (PUD) prophylaxis. 
The remaining components of the IHI bundle are elevation of the HOB to 30-45 degrees; daily 
interruption of sedation and assessment of readiness for weaning; and, added in 2010, routine 
daily mouth care using chlorhexidine. Sedwick, Lance-Smith, Reeder, & Nardi (2012) 
implemented the complete IHI bundle with the addition of mouth care every 2 hours (in addition 
to chlorhexidine daily); an alarm to prompt nurses if the HOB was less than 30 degrees; a 
handwashing protocol that required hand hygiene before and after care, and glove wearing 
during care; and subglottic suctioning via specialized endotracheal tubes with a suction port 
above the cuff; along with compliance monitoring and feedback to staff. Staff training on all 
components of the VAP prevention bundle was included as part of the project. These 
interventions decreased the VAP rate from 9.47 to 1.9 cases per 1000 ventilator days .  
 In a handbook published online by the Agency for Healthcare Research and Quality 
(AHRQ) for promoting healthcare safety, Kleinpell, Munro and Giuliano (2008) discussed 
evidence-based strategies for prevention of hospital-acquired pneumonia, including VAP. They 
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reported that hand hygiene is an important component for reducing hospital-acquired pneumonia. 
Other evidence-based recommendations from this study as they relate to VAP prevention 
included elevation of the HOB from 30-45 degrees; daily assessment of readiness for extubation; 
management of oropharyngeal secretions and oral care to minimize bacterial colonization and 
formation of biofilm; educating staff on prevention strategies; formation of a multidisciplinary 
team focused on VAP prevention; and communication to trigger and remind staff about the 
importance of VAP prevention. These recommendations converge well with those of the IHI 
ventilator bundle. 
Hand Hygiene  
The CDC (2002) and WHO (2009) have long promoted the importance of hand hygiene 
in prevention of hospital-acquired infections, and recommend direct monitoring of compliance. 
Koff, Corwin, Beach, Surgenor, & Loftus (2011) were able to show a nearly 50% reduction in 
VAP cases after implementation of an intensive hand hygiene program. Similarly, a study that 
examined the effect of chlorhexidine bathing and enhanced hand hygiene showed a significant 
decrease in ICU patient infection rates (Martínez-Reséndez et al., 2014).  
Oral Care  
With regard to oral care practices, a recent systematic review revealed that there is no 
clear consensus about the optimal protocol for oral care. Hillier, Wilson, Chamberlain, & King 
(2013) found that chlorhexidine was the most commonly used oral care product, but there was no 
standard for concentration or method of application. They found further that the most important 
factors for reducing VAP were having a standard oral care protocol, ongoing education of nurses, 
and evaluation of the program. Munro, Grap, Jones, McClish, & Sessler (2009) enrolled 
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ventilated patients in a randomized, controlled trial to receive mouth care with either 
chlorhexidine twice daily, toothbrushing three times daily, both together, or usual care. They 
found that chlorhexidine significantly reduced VAP in patients without pneumonia at baseline (p 
= .006), whereas toothbrushing did not, nor did it enhance the effect of chlorhexidine. In 
addition, a systematic review of oral decontamination for VAP prevention (Li, Xie, Li, & Yue, 
2013) found that decontamination of the oral cavity with antiseptics (chlorhexidine or povidone-
iodine) or antibiotics significantly reduced the incidence of VAP (risk ratio (RR) for antiseptics 
0.66, 95%, confidence interval (CI) 0.49-0.88; RR for antibiotics (except iseganan) was 0.27, 
95%, CI 0.18-0.42). A recent systematic review (Shi et al., 2013) reported moderate level 
evidence that a chlorhexidine rinse or gel resulted in significant reductions in VAP versus 
placebo or usual care (odds ratio (OR) 0.60, 95 % CI, 0.47-0.77, p< .001; number needed to treat 
(NNT) to prevent one episode of VAP = 15). Interestingly, neither Li et. al (2013) nor Shi et. al 
(2013) found any significant difference in mortality, ventilator days or ICU stay. These results 
clearly support the inclusion of chlorhexidine rinse as a component of care for VAP prevention. 
Backrest Elevation 
HOB elevation has also been shown to be an effective intervention for the prevention of 
VAP. In their systematic review of VAP prevention strategies, Collard, Saint, & Matthay (2003) 
found that there was relatively high-level evidence that a semi-recumbent position significantly 
reduced aspiration or VAP. Metheny, Davis-Jackson and Stewart (2010) additionally found that 
implementing an aspiration risk-reduction protocol in ventilated patients that included backrest 
elevation of 30 degrees or higher, along with feeding tube placement into the distal small bowel 
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versus usual care, resulted in a much lower pneumonia rate of 19%, vs. 48% before instituting 
the protocol. 
Subglottic secretion suctioning  
In accordance with the idea that aspiration of contaminated secretions contributes to 
development of VAP, the use of specialized endotracheal tubes that include an additional 
opening above the cuff attached to an external port to allow either continuous, intermittent or 
manual suctioning of subglottic secretions has been evaluated. A meta-analysis of randomized 
trials found that the use of these devices reduced VAP by nearly half (Dezfulian, et al., 2005), 
mostly by reducing early-onset pneumonia; however, it was also shown to decrease intubation by 
two days and ICU stay by three days, and delayed onset of pneumonia in longer-term intubations 
by 6.8 days. A more recent systematic review of RCT’s of the effectiveness of subglottic 
secretion suctioning for preventing VAP also found consistent evidence of its effectiveness 
(Scherzer, 2010). No complications to subglottic secretion suctioning were found in either this or 
the Dezfulian et.al. (2005) study. Implementing this strategy requires purchase and use of 
specialized endotracheal tubes, which may incur additional cost; however, an analysis by 
Dezfulian et. al (2005) showed a potential savings of $3535 per case of pneumonia avoided.  
Limiting duration of ventilation  
Interventions to limit the duration of ventilation are an important part of the ventilator 
bundle, given that the incidence of VAP increases with the duration of mechanical ventilation as 
does mortality with later-onset VAP. Strategies include using non-invasive positive pressure 
masks to avoid intubation, and protocols to facilitate weaning from the ventilator (ATS 
Documents, 2005). Daily sedation “vacations”, or decreasing the amount of sedation to allow the 
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patient to awaken and be evaluated for readiness to wean from the ventilator each day, was found 
by Kress, Pohlman, O’Connor & Hall (2000) to significantly reduce the length of time a patient 
is intubated, from 7.3 to 4.9 days, as well as decreasing the ICU stay from 9.9 to 6.4 days. A 
randomized controlled trial of a daily awakening from sedation combined with a spontaneous 
breathing trial (SBT) protocol versus sedation per usual care with a daily SBT resulted in 3.1 
days more of unassisted breathing, 3.8 fewer days in ICU and were discharged from the hospital 
4.4 days sooner in the intervention group. Patients receiving the intervention also were less likely 
to die, with a number needed to treat of 7.4 to prevent one death (Girard et. al., 2008).  
Summary of Literature on the VAP Bundle 
Despite the availability of clearly defined strategies that have been shown to be effective 
in reducing the incidence of VAP, nurse compliance with the recommendations is not consistent 
(Jansson, Ala-Kokko, Ylipalosaari, Syrjala, & Kyngas, 2013). The reason for this may be a lack 
of knowledge about the etiology of VAP or the bundle strategies, or of the rationale for specific 
interventions. In a recent survey of critical care nurses, Jansson et al. (2013) found that 
knowledge levels on EBP practices for VAP prevention were low, and nurses cited a lack of 
resources or disagreement with guidelines as the main barriers to implementation of the 
recommended strategies. Educating nurses on the ventilator bundle as part of a project to fully 
implement the IHI VAP prevention bundle is an effective way to support change and 
improvement.  
Conceptual Model/Theoretical Framework 
In keeping with the IHI’s (2012) recommendations for implementing the ventilator 
bundle, the Model for Improvement (IHI, 2014) will be used to guide the implementation of this 
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project. The model consists of two parts: the asking of three fundamental questions and 
executing the Plan-Do-Study-Act (PDSA) cycle. The three questions involve deciding what is to 
be accomplished; determining the measures that will indicate improvement; and selecting the 
strategies that will lead to improvement. In the PDSA model, a change is planned, then 
implemented, results are studied, and then the change is refined and the cycle can begin again. 
After completing the cycle several times, the change may be expanded and disseminated to other 
settings or organizations. 
In the application of the first phase of the model, goals for what is to be achieved must be 
identified. The goal for this project is that the VAP and VAE rates will be maintained at zero 
cases per 1000 ventilator days through 100% compliance with the ventilator bundle for 90% of 
the ventilator patients within one year. The strategies that will lead to improvement are 
enumerated in the IHI (2012) VAP bundle and include specific recommended actions for each of 
the five elements. For example, for the bundle element concerning daily oral care with 
chlorhexidine, one of the IHI-suggested actions is to ensure that a comprehensive process for 
oral care that incorporates chlorhexidine oral rinse is in place. Accordingly, a new oral care 
protocol, which is in compliance with current evidence-based recommendations, will be initiated 
in conjunction with the project. Information on the protocol will be included in the educational 
program for the nurses. The measures that will indicate improvement include the results of data 
collection. For each day of the study, this will include an assessment of the ratio of patients for 
whom all five bundle elements were performed, over the total number of ventilator patients for 
the day. The data can be trended over time to give feedback to the nurses as to whether the 
changes have been effective.  
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The PDSA cycle for implementing change begins with planning, selecting where the 
change will take place and whom will be included on the team. As there is only one ICU at the 
facility, this will be the venue for the change. Besides myself and the unit’s nurse manager, there 
will be involvement of the medical director, pharmacist, respiratory therapy department, and unit 
nurses.  I plan to identify one day shift and one night shift nurse and respiratory therapist as 
resource staff for the project. Nurses and therapists work together to care for the ventilator 
patient, and collaborate closely to assess readiness for weaning from the ventilator, as well as 
carrying out the spontaneous breathing trials. The pharmacist has been involved in facilitating 
the availability of chlorhexidine oral rinse in unit doses, with bar-code scanning labels. The rinse 
had not previously been on the formulary, and the bar-code scanning ability will enable tracking 
of compliance with dosing. The unit’s medical director is another key person, who supports the 
change and can help reinforce with the other medical staff the importance of ensuring that orders 
are entered for the patient in compliance with the VAP bundle. Planning also includes preparing 
an educational program for nurses, to promote their understanding of the need for change, and 
facilitate their understanding of how to accomplish the change. 
The next step of the PDSA cycle is to put the plan into action. The IHI (2012) 
recommends starting with one patient upon intubation, ensuring that all nurses caring for the 
patient understand the VAP bundle and are able to carry it out from shift to shift. Feedback on 
the experience is used to improve the process, which is then expanded to every intubated patient. 
Once the process is fully implemented, the “study” portion of the PDSA cycle calls for data 
collection on VAP bundle compliance as outlined above, and on VAP/VAE rates. The VAE rates 
are included because although the ultimate goal is VAP prevention, VAE rates are reportable to 
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the National Healthcare Safety Network (NHSN) (Centers for Disease Control, 2013), and affect 
future reimbursement rates under CMS guidelines. Finally, the results of data collection will 
guide what further revisions need to be made. These results will be graphed on a run chart and 
shared with the nursing staff, to help motivate them to continue to improve. 
Summary of Literature Review 
As been shown in this subsection, there is strong support for the strategies outlined in the 
IHI (2012) ventilator bundle. Educating staff on the rationale and importance of each component 
of the bundle as part of an evidence-based practice project is a strategy that has been successfully 
employed for VAP prevention (Hutchins, Karras, Erwin, & Sullivan, 2009; Sedwick, Lance-
Smith, Reeder, & Nardi, 2012). Following the IHI’s improvement model will support the 
likelihood of success of the project by providing a guiding framework for the activities. 
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Section 3: Approach 
Introduction 
The purpose of this project is to determine the effect of an evidence-based VAP 
educational program on actual and documented ICU nursing care practices for preventing VAP. 
Implementation of an evidence-based practice project can take a variety of forms (White, 2012). 
According to White and Zaccagnini (2011), an evidence-based practice project should include 
structured and thorough data collection, as well as statistical analysis to determine the 
significance of the data and project outcomes. This section will describe the methodology of the 
study: design, data collection, population, data analysis and evaluation plans, and provisions for 
human subjects protection. 
Project Design/Methods 
A quasi-experimental, interrupted time-series design will be used. This design is used 
when observations as listed in the data collection checklist (see table 1 p.23) are recorded, then 
an intervention (the educational program) “interrupts” the data collection, data collection 
resumes after the intervention, and comparisons are made between scores before and after the 
intervention. This design is appropriate for practice-based interventions for which randomization 
and control group assignment would not be ethical because the known benefits of the 
intervention would be withheld from some participants (Handley, Schillinger, & Shiboski, 2011). 
In this case, the dependent variables will be the change in actual practice related to the 
VAP/VAE prevention bundle and hand hygiene, and documentation of the bundle components 
after the educational intervention. The independent variable is the educational intervention. The 
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rates of VAEs and VAP per 1000 ventilator days will also be compared for the 3 months before 
and for 3 months after the intervention. 
Population and Sampling 
This project will involve all full-time, part-time and unit-specific per diem critical care 
nurses working within a seven-bed adult ICU of a community hospital in upstate New York. 
Employed in this unit are 15 full-time, 2 part-time and 2 per diem nurses. There is one part-time 
nurse on each shift, and one per diem nurse on each shift. The nurses range in age from 28–63. 
The majority of the nurses possess an Associate’s degree as their highest nursing degree. One 
nurse on each shift has a Bachelor’s degree. A full-time day nurse and the per diem night nurse 
have Master’s degrees. Their years of RN experience range from 5–35 years and ICU experience 
from 2–35 years.  
The nurses will be given an educational program in the form of a power point slide show, 
to be accessed via the facility’s intranet system. Included in this slide show will be information 
about how VAP/VAE is defined; the risk factors for VAP/VAE; the importance of VAP/VAE 
prevention; the components of and rationale for the ventilator bundle elements; and strategies for 
successful implementation of the bundle. I will explain and expand on the content. Data related 
to VAP/VAE will be collected on all ICU patients who remain intubated more than 24 hours. 
To evaluate the educational program, their satisfaction with the program will be assessed 
using a survey of the type commonly administered after educational activities (see Appendix C). 
It will ask participants to indicate whether they agree or disagree with statements on a Likert-
type scale. Open-ended questions will also be included to request comments on what would 
make this course better and what additional information is needed. The survey would be given 
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immediately after each participant completed the training and any feedback incorporated in a 
formative fashion. Any additional information that is deemed needed to add to the program will 
be communicated to any participants to whom it had not originally been included.  
Data Collection 
Electronic medical records for all intubated patients admitted to the unit for the 3 months 
before the intervention and 3 months after the intervention will be audited for documentation of 
the frequency of oral care and whether chlorhexidine rinse was used, how many hours per day 
the head of the bed was elevated to 30-45 degrees, whether patient had a daily sedation vacation 
and assessment of readiness for extubation, and if not, whether there was a documented 
contraindication. Compliance with the additional bundle measures concerning deep vein 
thrombosis (DVT) and peptic ulcer disease (PUD) prophylaxis will also be tracked, since these 
are components of the IHI (2012) ventilator bundle, all of which should be included in a 
comprehensive approach to care for the ventilated patient. Compliance with the bundle will be 
counted as complete only if all five components have been met. If there is a documented 
contraindication to a component that was not done, compliance will still be affirmed. The results 
will be compared on the same measures for the 3 months after the intervention. In addition, 
observations will be made of VAP bundle-related care being given to one ventilated patient in 
the unit twice each week during the first hour of each 12-hour shift for four weeks prior to the 
intervention and in the final four weeks of the project to verify the accuracy of the associated 
documentation. Information on the usage levels of oral care kits per ventilator day for 3 months 
before and 3 months after the educational intervention will also be collected by auditing 
stockroom orders as a proxy measure of the frequency of oral care provided. In terms of 
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outcomes, the rates of VAEs and VAP will be compared for the period of 3 months before and 3 
months after the intervention.  
Descriptive statistics on the characteristics of the nurses, including age, sex, their 
educational attainment level, number of years as an RN, years in critical care, and length of time 
employed at the facility and in the unit, will be included in a table. In addition, data will be 
collected on actual practices of nurses involving the oral care elements of the ventilator bundle 
and hand hygiene during 1-hour observations, with the use of a checklist (see Table 1). A score 
will be calculated on what percentage of the observations the practices were carried out to the 
levels expected according to the oral care protocol and ventilator bundle (IHI, 2012), as well as 
the WHO (2009) hand hygiene recommendations.   
In addition, data will be collected through chart review on each ventilated patient using a 
data collection form (see Appendix D) on their duration of intubation, ICU and hospital length of 
stay, and whether they died before discharge. A score on the Acute Physiology and Chronic 
Health Evaluation II (APACHE II) classification system (Knaus, Draper, Wagner, & 
Zimmerman, 1985) will also be calculated for each patient on the day of initiation of mechanical 
ventilation, to enable comparison of patient acuity before and after the intervention (see 
Appendix E). This scale assigns points for indicators of acute physiological dysfunction, such as 
serum creatinine and temperature, and also for the patient’s age, and presence of chronic health 
conditions. The APACHE II has been shown to be a valid predictor of 30-day mortality in 
patients with VAP (Zhou, Ben, Chen, & Ni, 2014). The data collection form will also record 
whether the patient had a daily sedation vacation and assessment of readiness for extubation, as 
well as DVT and PUD prophylaxis (or documented contraindication), the documented frequency 
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of oral care and number of hours that the HOB elevation was between 30 and 45 degrees each 
day of intubation, beginning at 24 hours after intubation and continuing until extubation.  
Protection of Human Subjects 
Human subject protection will be provided through the institutional review board (IRB) of 
Walden University (IRB approval number 06-05-15-0414936). A data use agreement was also 
granted by the agency in which the project is to take place. In addition, since it is an evidence-
based practice improvement project, nurses involved in the process will not need to give consent 
(Terry, 2012). To protect privacy, no information that could be used to identify a patient or nurse 
will be collected. A separate file will be kept to link the patient and nurse information to a 
number on the data collection form and the files will be kept secure and confidential in a 
password-protected computer within the hospital. 
Table 1  
Data Collection Checklist 
Observation #____ Nurse # _____ Patient # ______ Circle: Pre- or Post-education  
1. Oral care yes no 
Deep suctioning of oral cavity/pharynx   
Brush teeth with suction toothbrush   
Swab with chlorhexidine   
2. Head-of-bed elevation between 30-45 degrees   
Actual elevation (degrees)    
3. Hand hygiene   
Performed on entering the room   
Performed on leaving the room   
Gloves worn for oral care   
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Data Analysis 
Data analysis will consist of paired t tests, to compare the mean compliance rates of the 
nurses with each element of oral care and hygiene practices as noted on the data collection form 
before and after the intervention (Grove, Burns, & Gray, 2013). Paired t tests will also be 
performed on the questions of whether there was a difference in rates of patients having a daily 
sedation vacation and assessment of readiness for extubation, and were given DVT and PUD 
prophylaxis, and if they did not, whether there was a documented contraindication. The mean 
duration of ventilation, mean ICU length of stay and hospital length of stay, mortality before 
discharge, and rates of VAP and VAEs per 1000 ventilator days before as compared to after the 
intervention will be analyzed using ANOVA. Descriptive statistics will be used to characterize 
the nurses on the variables of age, years of RN and critical care experience, educational 
attainment, and years of employment in the unit, through use of frequency distribution tables. 
Grouped frequency distribution tables will be used to categorize the nurses’ ages in 10-year 
increments (e.g., age 20-29, 30-39, etc.) by number and percentage in each category. Years as an 
RN, years in critical care and years working in this unit will be grouped in 5-year increments (0-
4 years, 5-9 years, etc.). Number and percentage of nurses with each level of educational 
attainment (from Associate’s to Master’s) will also be displayed in tabular form.  
Project Evaluation Plan 
The goals, objectives and activities of the evaluation plan will need to include elements 
of performance measurement, monitoring, and overall evaluation of the project (Kettner, 
Moroney, & Martin, 2013). These may include formative and summative strategies, as well as 
process, impact and outcome evaluations (Hodges & Videto, 2011). As such, it is an ongoing 
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process throughout the project that seeks to determine whether the project is being implemented 
according to the intended design, whether it is accomplishing its intended goals, is cost-effective, 
and whether the outcomes can be attributed to the program. The specific activities will coincide 
with data collection to be carried out for the program. The types of data that can be sources of 
measurable changes attributable to the program may include numeric counts, standardized 
measures, level of functioning scales, and client satisfaction (Kettner, Moroney, & Martin, 
2013).  
Monitoring activities relate to formative evaluations of the processes of the project to 
evaluate fidelity to the intended design. To evaluate the effectiveness of the educational program, 
changes in observed and documented compliance with elements of the VAP/VAE prevention 
bundle will be monitored throughout the project. This will be done by sharing the results of the 
data collection checklist of observed activities (see Table 1) as well as data on the client data 
collection form (Appendix D), to give nurses feedback on their performance in a formative 
fashion to allow them to take corrective action. The data will also be summarized weekly and 
provided in the form of a “dashboard” to give the nurses information about performance in the 
unit overall.  
Overall evaluation of the project involves a summative determination of the impact on 
short and long-term goals of the project, and whether it achieved its objectives. Objectives 
related to the overall goal include that all ICU nurses will perform and document 100% of 
recommended nursing actions for VAP prevention and that VAP/VAE cases will be maintained 
at zero cases per 1000 ventilator days. The evaluation is accomplished by comparative analysis 
of these data before and after the educational intervention and the implementation of the 
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program. Cost effectiveness will also be analyzed relative to the cost of additional patient care 
supplies compared to the cost savings of each VAP or VAE case avoided. 
Summary 
The methods outlined for the project are intended to determine the effects of an 
educational program on the VAP prevention practices utilized by nurses. By observing the 
nurses’ care practices and examining their documentation both before and after the educational 
program, comparisons can be made to discern whether their compliance with the recommended 
practices increases. Also important to analyze are data on nurse and patient demographics, 
patient acuity, and nurse satisfaction with the educational activity. 
The development of VAP or VAEs can result in significant morbidity, mortality and 
potential costs in both financial and human terms for critically ill ventilated patients (Ibrahim, 
Tracey, Hill, Fraser, & Kollef, 2001). Currently, knowledge of and compliance with the policies 
and practices included in the ventilator bundle is not consistent among nurses. If critical care 
nurses are educated about the risks for and importance of preventing these infections, and are 
knowledgeable about the measures shown to be effective for prevention, they will be more likely 
to employ them. If they do, this will provide patients with the best possible scenario for 
avoidance of potentially devastating complications. 
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Section 4: Evaluation and Discussion 
Introduction 
The purpose of this project is to examine the effect of an evidence-based VAP 
educational program on the on the actual and documented ICU nursing care practices for 
preventing VAP. Additional purposes are to determine whether the nurses were satisfied with the 
knowledge gained from the educational program, and whether the severity of illness of the 
patients as measured by the APACHE II scale would differ from pre- to post-intervention. The 
project has two goals: at least 90% compliance with all five components of the ventilator bundle 
and maintenance of a zero rate of VAP for the duration of the project period.  Because the 
project has not been fully implemented, there are no results to report.  This section will discuss 
the potential for using the results in evidence-based practice. 
Evaluation and Discussion 
Before beginning the project, the oral care policy and protocol for patients on a ventilator 
was revised. It consisted only of providing oral care every 8 hours. The protocol revision called 
for oral care every 2 hours, and outlined specific steps to be followed. Second, it specified the 
use of chlorhexidine gluconate 0.12% rinse every 12 hours, as recommended by the IHI VAP 
prevention guidelines (2012). Since chlorhexidine gluconate had not previously been used in this 
hospital, it had to be added to the hospital formulary. A barcode for scanning was required to 
ensure the drug is properly documented in the EMR system. Accomplishing this was a major 
success of the project.  
All physicians credentialed to write orders for ventilator patients were made aware of the 
availability of the drug and were encouraged to prescribe it for all ventilator patients. (The 
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practice is supported by the medical director of the ICU.) The new protocol calls for a nurse to 
contact the physician for orders or for clarification if the drug is not ordered initially for the 
ventilator patient. .  
Although the new oral care protocol was introduced more than 6 months ago, some 
physicians are still not consistently ordering the chlorhexidine rinse for their ventilator patients. 
And although nurses were given the new protocol to read, they have not been trained on the 
overall VAP prevention bundle. This program is anticipated to be given through the hospital’s 
intranet educational system, at the end of September, 2015. 
A new EMR system was implemented prior to any project activities.  It included a section 
for documenting the five practices of the ventilator bundle which will facilitate collecting 
evidence of compliance. Upon implementation of the project, the EMR will reveal the number of 
times per day chlorhexidine was administered to the patient, as well as whether the rest of the 
VAP bundle practices were implemented. The goal of the project will be considered to have been 
met if there was 100% compliance, meaning all five practices were completed on 90% of 
ventilator days.  
The EMR also contains an order set for ventilator patients that includes options for 
inclusion of all the bundle elements. It can act as a checklist to prompt the ordering provider to 
elements that may otherwise be missed. Providers must be encouraged to use this bundle as 
opposed to ordering “ala carte” to allow for consistency. Nurses are also empowered via the oral 
care policy protocol to request an order from the provider for chlorhexidine rinse. In addition, the 
educational program for the nurses encourage them to document the five bundle elements and 
prompt the ordering provider should they find an element has not been addressed. 
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Observations of care being given are intended to determine whether the oral care 
procedures are being done according to the policy, and whether the documentation of the bundle 
elements accurately reflects care practices. Substantiation of whether documentation reflects 
actual practice is an important element for increasing the validity of the assumption that 
documented activities are actually being performed. Observations will be compared to 
documentation for the same period, and the accuracy of documentation will be assessed by 
calculating a percentage of documented versus observed care activities. 
The educational program to be provided to the nurses consists of a power point 
presentation covering the definition of VAP, its risk factors, the importance of prevention, and 
prevention strategies. Narration of the presentation is included to provide more detail and to 
appeal to the auditory learner. The educational program is to be assigned to all ICU nurses 
through the facility’s intranet platform for online educational offerings, and will be a required 
course. The course evaluation will be presented at the end of the activity. User tracking is 
available to verify that all nurses have completed the activity. 
VAP rates at this facility for the 2 years prior to initiation of the project have remained at 
zero cases per 1000 ventilator days according to published data. There was concern that 
simplified reporting criteria enacted in January 2013 would result in increased likelihood of 
identification of cases. The expected effect of this project would be maintenance of this rate of 
zero cases. To date the rate of zero cases has been maintained in this unit.  
Implications 
Implementation of a VAP prevention bundle promises to keep secure the trend of zero 
cases of VAP despite more broad criteria for diagnosing it being adopted. In terms of the benefit 
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to patients, this project serves as an example of how the translation of research to practice is 
vitally important for improving care and preventing complications that are potentially avoidable. 
This is a step for positive social change, as it contributes to quality improvement and decreases 
in patient suffering and/or demise. In terms of policy, the project makes clear that an institution 
needs to have protocols and procedures in place that are in line with evidence-based practice 
advances. However, it is not enough to have the policies in place – educating the stakeholders on 
the rationales and basis in science of changes that are enacted are key to effecting lasting 
improvements. 
Project Strengths and Weaknesses 
The strengths of the project are first that it is based on accepted standards of evidence-
based care. The IHI (2012) ventilator bundle has been widely used and multiple published 
accounts have demonstrated its effectiveness for reducing ventilator-associated pneumonia. The 
evidence continues to accrue. Righi et al. (2014) found a significant decrease in ventilator-
associated pneumonia rates with implementation of a VAP bundle, which included chlorhexidine 
oral rinse.  
An additional strength is that in focusing on an educational intervention for nurses, there 
is an opportunity for the involvement of the front line caregivers in improving the quality of care. 
Their role as a part of a collaborative team is emphasized through the educational program. By 
creating a collaborative team in which the contributions of the members is recognized and 
valued, a shared responsibility for the outcomes is developed (Ash & Miller, 2011).  
One notable weakness is that although observations will be carried out to confirm the 
fidelity of documentation to actual practice, one cannot be present in all instances where care is 
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taking place. In addition, nurses who know they are being observed may perform differently than 
when they are not being observed, and so the observations may not accurately reflect actual 
practice. In addition, it is unknown what effect the change to the oral care protocol prior to the 
initiation of the project has had on the incidence of VAP. It may be difficult to determine 
whether the maintenance of zero VAP cases was due to the new oral care protocol, or to the 
educational program.  
Future evidence-based practice or research projects would help further the study of the 
problem of VAP. One topic could be to determine what is the optimal frequency and method for 
oral care, other than using chlorhexidine. This is an undecided issue based on the current 
literature (Hillier, Wilson, Chamberlain, & King, 2013).    
Analysis of Self 
The role of the DNP is that of expert clinician, scholar, and change agent in the 
promotion of advanced nursing practice (Tymkow, 2011). The evidence-based practice project 
can be seen as the culmination of the knowledge gained in the program of study and its practical 
application in the clinical practicum. The DNP Essentials (2006) call for the application of 
clinical scholarship and analysis of data to help design interventions and programs that are 
evidence-based. This translation of research into practice is a major role of the DNP and is a key 
to improving outcomes for patients and the health care system overall (IOM, 2001). Through in-
depth inquiry in an area of clinical importance, the DNP takes a scholarly approach to a problem 
and uses leadership skills to bring about change in an organization. With regard to these 
definitions, I have had successes, but also a few missteps that have served to stimulate my 
development. 
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The DNP Essentials document (American Association of Colleges of Nursing, 2006) 
describes the advanced practice competencies of the DNP graduate as developing specialized 
expertise in a particular area of advanced practice, through the application of knowledge in the 
varied areas of physical and social sciences. These competencies extend across a variety of 
specialties and patient care settings, and include the ability to evaluate evidence-based care 
taking a systems view, as well as educating and mentoring others toward promoting optimal 
health outcomes. The DNP project has been the main vehicle for me in achieving these goals. 
Not only has it helped me to learn how to evaluate literature for best practices in relation to a 
clinical issue, but it also incorporated translation of this evidence into nursing care 
improvements, as well as the teaching and mentoring of the nursing staff who will ultimately be 
tasked with enacting the changes. 
Leadership can be described as the ability to motivate and guide others toward the 
achievement of goals, through communication of vision and values (Ezziane, 2012). Through my 
experiences with leadership in the project, I have pushed out of my comfort zone to assume the 
responsibility for setting the tone and providing the vision for the need for change. Having to 
develop my own voice to communicate a larger picture of what can be accomplished in order to 
facilitate change in the organization is probably one of the most valuable skills that I have 
developed. My confidence in this area has increased tremendously and I now feel that the 
possibilities are limitless for being able to effect change in any organization. 
In terms of project management, since the project has not yet been implemented, it 
remains to be seen how successful the effort will be. Through the preliminary steps that have 
been taken so far, there has been some success, but work remains to be done. According to 
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Harris & Roussel (2011), successful project planning and management requires one to be flexible 
and adaptable, and include stakeholders in the process early on. While the medical director has 
supported the project from the beginning, other physicians have not been fully on board. This 
will need to be addressed going forward, and will involve educating these stakeholders through 
presentation of the evidence on which the project is based. In addition, once implementation 
begins, adjustments may need to be made based on input from the nurses involved. In an effort to 
fully engage them, it will be important to recognize their value and expertise toward the 
successful implementation of the project. 
Summary and Conclusions 
This project’s goal is to prevent VAP by way of an educational program for nurses on the 
ventilator-associated pneumonia prevention bundle, along with implementing a new oral care 
protocol. Data showing nurses’ compliance with the bundle elements, and high levels of 
satisfaction of the nurses with the education received, can be construed as evidence of success of 
the project. The VAP prevention bundle is now the standard of care nationally, as supported by 
numerous research studies and the endorsement of several agencies that are concerned with the 
quality and safety of patient care: Institute for Healthcare Improvement (2012), Healthcare and 
Infection Control Advisory Committee  of the CDC (Tablan, Anderson, Besser, Bridges, & 
Hajjeh, 2004), CMS (, 2013), and the Society for Healthcare Epidemiology of America (2014). 
The value of showing adherence to these guidelines is evident in that it reflects the commitment 
of the facility to maintaining the highest standards of evidence-based practice. This is especially 
relevant because the future of health care promises to reward those organizations that are 
successful in protecting their patients from preventable harms.   
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Section 5: Scholarly Product for Dissemination 
Project Summary 
Introduction 
The project, entitled “Ventilator Associated Pneumonia Prevention Bundle” is a quality 
improvement project aimed at educating Intensive Care nurses on the prevention of ventilator-
associated pneumonia (VAP). The education focused on the risk factors and prevention strategies 
for VAP, and on the ventilator ‘bundle”, a group of interventions that when performed together 
have been shown to reduce the incidence of VAP (Institute for Healthcare Improvement, 2012). 
The project was designed to answer the following questions: 1) What is the effect of an 
educational program focused on VAP prevention guidelines, rationales, and strategies on critical 
care nurses’ compliance with the VAP prevention bundle, as measured by observed and 
documented oral care with chlorhexidine per protocol, elevation of the head of the bed to 30 - 45 
degrees, daily sedation vacations and assessment of readiness for extubation; 2) Will the 
education result in the maintenance of a rate of zero cases of VAP and VAEs per 1000 ventilator 
days for the 3 months after the educational intervention; 3) What will be the nurses’ level of 
satisfaction with the educational program;  and, 4) Will there be a difference in the severity of 
illness as measured by the APACHE II score for patients enrolled before the intervention versus 
after the intervention? 
Project Purpose and Outcomes 
The purpose of the project was to determine the effect of an evidence-based VAP 
educational program on actual and documented ICU nursing care practices for preventing VAP. 
The practices for this project derive from the Institute for Healthcare Improvement’s (IHI’s) 
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(2012) “ventilator bundle” (VB) that consists of the following five interventions: 1) Performing 
oral care with chlorhexidine gluconate oral rinse every 12 hours; 2) Maintain the head of the bed 
at 30-45 degrees; 3) Ensure a daily “sedation vacation” in order to assess patient readiness to 
wean from the ventilator;  4) Provide prophylaxis for deep vein thrombosis; and, 5) peptic ulcer 
disease prophylaxis. Education is provided to the ICU nurses by use of a slide show that includes 
information about how VAP/VAE is defined; the risk factors for VAP/VAE; the importance of 
VAP/VAE prevention; the components of and rationale for the ventilator bundle elements; and 
strategies for successful implementation of the bundle. It includes narration by to explain and 
expand on the slide content, which also reviews the oral care protocol in depth. 
A secondary project purpose was to determine the effect of the educational program on 
the outcome of cases of VAP and Ventilator-Associated Events (VAEs). Although the IHI 
bundle (2012) addresses only VAP, VAEs are included in this project as an outcome because as 
of January 2013, they are reportable to CMS, and in the future may result in reduced payments to 
hospitals under pay-for-performance computations. The objective of the implementation of this 
project was to avoid the preventable complication of VAP and VAEs, maintaining a rate of zero 
cases per 1000 ventilator days. This project has not yet been implemented. A new oral care 
protocol was developed that included chlorhexidine gluconate oral rinse in preparation for the 
project and assigned to be read by the nurses. When the educational program is assigned in late 
July 2015, renewed emphasis on the new oral care protocol will be included. 
Theoretical Framework 
The Model for Improvement (Institute for Healthcare Improvement, 2014) was used to 
guide the implementation of this project. The model consists of two parts: the asking of three 
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fundamental questions and executing the Plan-Do-Study-Act (PDSA) cycle. The three questions 
involve deciding what is to be accomplished; determining the measures that will indicate 
improvement; and selecting the strategies that will lead to improvement. In the PDSA model, a 
change is planned, then implemented, results are studied, and then the change is refined and the 
cycle can begin again. After completing the cycle several times, the change may be expanded 
and disseminated to other settings or organizations. This model, which was developed by the 
same organization that developed the ventilator bundle, is well suited for the project because the 
implementation of a practice change such as this requires refinement of the approach as 
experience is gained. The expected outcomes of the project are that the new oral care protocol is 
followed consistently by the nursing staff; that all VAP bundle elements are reliably performed 
and accurately documented; and that a zero rate of VAEs and VAP will be maintained. 
Implications for Practice 
This project is intended to provide ICU nurses with the ability to make evidence-based 
care decisions, and to monitor compliance with the VAP bundle. Clinicians have a responsibility 
to provide evidence-based care aimed to improve patient outcomes and to reduce patient risk for 
harm. The interventions included in the educational program have been the standard of care 
nationally for several years, and to neglect instituting them represents a failure of the 
organization to ensure the highest quality of care to their patients. 
Specific implications for practice attributable to the project include several benefits. First, 
prevention of VAP can be financially advantageous to the institution, since VAP is considered 
preventable by CMS (Centers for Medicare and Medicaid Services, 2013), which will not 
reimburse the costs of care. Secondly, benefits to patients may include decreased ventilator days, 
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ICU and hospital stays (Metheney, Davis-Jackson, & Stewart, 2010), and even fewer deaths 
(Girard, et al., 2008). Finally, nurses may report increased satisfaction with their level of 
knowledge regarding VAP prevention as a result of the educational program. Patient satisfaction 
may increase owing to decreased complication rates and lengths of stay, which in turn can have 
positive effects on nurse satisfaction. 
Plans for Dissemination 
Once the educational program has been presented to the nurses within the ICU of the one 
facility, results of the satisfaction surveys and the feedback of the nurses will be incorporated and 
any needed changes to the program will be initiated. Since this facility is part of a larger health 
system, and has two sister hospitals, the educational program will be extended to include the 
other hospitals as well. Currently neither of the other hospitals has in place a policy and 
procedure for VAP prevention that includes the evidence-based components of this project, such 
as using chlorhexidine oral rinse. Consequently, these hospitals lag behind in implementation of 
the national standard of care. The new EMR contains the outline of a procedure which should 
facilitate the project. When implemented, the project operationalizes the full development of the 
policy and procedure to bring the facility into compliance with current guidelines. 
In terms of a wider dissemination of the project, the project summary can be presented at 
a nursing conference via a poster board presentation (see Appendix G) including the results of 
the data analysis after project completion. Two possible candidate conferences include the 
American Nurses Credentialing Center Pathway to Excellence conference in April 2016 
(American Nurses Credentialing Center, 2014), or a Contemporary Forums conference, which 
are offered in several specialty areas, including critical care (Contemporary Forums, 2015). In 
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addition, submission to a journal such as Critical Care Nurse or the American Journal of 
Infection Control is planned for publication of the project and results. Through these media, the 
project imparts national and global impact toward the goal of promoting evidence-based practice 
through clinical scholarship as called for in the DNP Essentials document (American Association 
of Colleges of Nursing, 2006). 
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Appendix A. Ventilator-associated events surveillance algorithm  
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Appendix B. Oral Care Policy 
PURPOSE 
To promote safety by: 
Standardization of oral care practices according to evidence-based guidelines 
Prevention of ventilator-associated events (VAE) and ventilator-associated pneumonia 
 
POLICY 
Patients on a ventilator will have oral care performed every 2 hours and as needed using 
the identified equipment and procedure noted below. Two of the episodes of oral care will 
include the use of chlorhexidine gluconate oral rinse. 
ROLES & RESPONSIBILITIES 
1. Vice President Patient of Care Services & Medical Director  
The Vice President of Patient Care Services, in collaboration with the Medical Director has 
overall responsibility for implementation of the oral care protocol. 
2. Medical Staff  
Medical Staff and collaborating practitioners facilitate adherence to the protocol by initiating 
applicable orders for patients on a ventilator. They also cooperate with the facility's quality 
improvement, patient safety and risk management procedures.  
Topic:                                                   Code No.                      Date:     9/14 
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3. Clinical Directors and Supervisors and Clinical Director of Staff Development  
Ensures that caregivers within the unit are provided with education and training on oral care 
protocols and equipment, and ensures that they are utilized appropriately. Identifies and 
reports potential barriers to implementation of the protocol. 
4. Admitting/Staff Nurse  
a. The RN will verify that the patient has orders for oral care according to the protocol upon 
intubation. 
b. If there are no orders written for oral care, the RN will seek such orders through 
collaboration with the physician or provider for the patient. 
c. If the patient has contraindications to the protocol being implemented as specified, the 
nurse will notify the provider and document the reason. 
d. Is responsible for performing the oral care on the specified schedule and documenting it 
on the electronic medical record, including bar code scanning of the chlorhexidine rinse 
as ordered. 
  PROCEDURE 
1. An assessment of the condition or the oral cavity, teeth, gums and mucosa should be 
documented on the Complex or Simple Assessment flowsheet every shift and whenever there 
is a change in status. 
2. Oral care will be performed every two hours using the commercial oral care kit (Sage® Q 
Care Q 4 hour,) according to the procedure outlined in this policy and the Lippincott Manual 
under Critical Care: Oral Care for an Intubated Patient, available through the link:  
http://procedures.lww.com/lnp/view.do?pId=2349172 
52 
 
a. Two of the episodes of care daily will include the use of chlorhexidine rinse 
according to the following procedure: 
b. Barcode scan chlorhexidine gluconate (Peridex) 15 mL as ordered on MAR. 
c. Perform deep oropharyngeal suctioning using the long catheters supplied in the 
Sage® Q Care Oral Care Kit. 
d. Open the package with the suction toothbrush by laying it on a flat surface and 
peeling back the top. Pour the chlorhexidine into the open package. Saturate the 
suction toothbrush with the solution and brush all surfaces of the teeth and tongue. 
e. Saturate the applicator swab included in kit with chlorhexidine and coat all surfaces 
of teeth, tongue and gums. Suction any remaining fluid from the mouth. Do not rinse 
with water or apply mouth moisturizer. 
f. The Sage® Q Care Q 4 hour kit provides equipment for 6 episodes of oral care per 
day, including 2 suction toothbrushes to be used with chlorhexidine application, 2 
oropharyngeal catheters, and 4 kits containing a suction swab, Perox-a-mint® 
solution packet, and an applicator swab for applying mouth moisturizer. The 
moisturizer is to be used each time oral care is given EXCEPT those in which 
chlorhexidine is used. 
3. For additional episodes of care (6 per day), single-supplied kits including a swab with 
Perox-a-mint® solution packet and an applicator swab with mouth moisturizer may be used 
(Sage®).  
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4. The plan of care for ventilated patients includes risk for ventilator-associated pneumonia as 
an identified problem. The nursing care plan is reviewed when the patient is assessed daily 
and the appropriate interventions are initiated according to the care plan 
5. Patient/family education  
a. Determine what the patient and/or family knows about oral care and prevention of 
ventilator-associated pneumonia. Education is not complete until confirmation of patient 
and/or family understanding has been adequately obtained. 
b. Document teaching on the appropriate documentation flowsheet. 
6. Documentation and Communication  
a. Document each episode of oral care performed using chlorhexidine on the flowsheet 
under the “adult ventilator-associated pneumonia bundle” documentation (every 12 
hours). These rows may need to be “pulled in” from the cascading group (green arrow in 
trigger row) next to “Age-specific ventilator-associated pneumonia bundle” by selecting 
“Adult” from the cascade options. 
b. Document additional episodes of oral care (NOT using chlorhexidine) under the “PCT 
Daily Care” flowsheet in the “Hygiene” row (select “mouth care”), noting any unusual 
conditions or responses. 
c. Communicate any issues related to the patient’s oral assessment and care, primarily 
through off-going and on-coming RN communication at the change of shift, and 
including respiratory care staff. 
STAFF EDUCATION AND COMPETENCY 
Staff education will be provided during initial orientation and annual reorientation.  
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INCIDENT REPORTS 
Any Incident Reports of adverse events related to the oral care protocol will be completed 
in Quantros and forwarded as defined in the Patient Safety/Risk Management Plan.  
PERFORMANCE IMPROVEMENT 
Data on cases of ventilator-associated pneumonia and events will continue as per 
Infection Control procedure.  
References 
Lippincott Procedures (2014). Wolters Kluwer Health. Retrieved from: 
http://procedures.lww.com/lnp/home.do?m=selection&d=485 
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Appendix C. VAP Prevention Post-Education Survey 
Please rate your level of agreement with the following statements on a 5-point Likert scale:  
1 = Strongly disagree 2= Disagree 3= Neither agree nor disagree  
4= Agree  5 = Strongly agree 
1. After the educational program, I developed a better understanding of the pathophysiology of 
VAP 
o 1. Strongly disagree   
o 2. Disagree   
o 3. Neither agree nor disagree   
o 4. Agree   
o 5. Strongly agree 
 
2. I know the risk factors for developing ventilator associated pneumonia. 
o 1. Strongly disagree   
o 2. Disagree   
o 3. Neither agree nor disagree   
o 4. Agree   
o 5. Strongly agree 
 
3. After the educational program, I better understand the importance of VAP prevention. 
o 1. Strongly disagree   
o 2. Disagree   
o 3. Neither agree nor disagree   
o 4. Agree   
o 5. Strongly agree 
 
4. I am confident that I can apply the VAP bundle elements in the care of the ventilator patient 
o 1. Strongly disagree   
o 2. Disagree   
o 3. Neither agree nor disagree   
o 4. Agree   
o 5. Strongly agree 
 
5. The instructional methods were effective for meeting the objectives of the course. 
o 1. Strongly disagree   
o 2. Disagree   
o 3. Neither agree nor disagree   
o 4. Agree   
o 5. Strongly agree 
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6.  I am familiar with my unit's oral care protocol. 
o 1. Strongly disagree   
o 2. Disagree   
o 3. Neither agree nor disagree   
o 4. Agree   
o 5. Strongly agree 
 
What would make this course better? 
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________ 
  
What additional information do you need to improve VAP-prevention in your unit? 
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________ 
 
Please share any other comments you may have. 
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
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 Appendix D. VAP Prevention Project Client Data Collection Form 
Patient number ______ Pre or  Post  Intervention (circle)  Deceased yes  no  (circle) APACHE II score on day of intubation _____ 
Hospital admission date ____ Hospital discharge date _____Hospital length of stay  ____ 
ICU admission date _______ ICU discharge date ________  ICU length of stay _______ 
Date of intubation ________Date of extubation ________  Days on ventilator _________ 
Ventilator 
day 
# of hours 
HOB 
documented 
to be at 30-
45º per 24h  
# times oral 
care 
documented 
per 24 hours 
# times 
chlorhexidine 
oral rinse used 
in oral care 
per 24 hours 
Had sedation 
vacation 
or 
contraindication 
documented 
Had assessment 
of readiness for 
extubation or 
contraindication 
documented 
DVT prophylaxis 
or 
contraindication 
documented 
PUD prophylaxis 
or 
contraindication 
documented 
Compliance 
met 
2    Yes  No Yes  No Yes  No Yes  No Yes  No 
3    Yes  No Yes  No Yes  No Yes  No Yes  No 
4    Yes  No Yes  No Yes  No Yes  No Yes  No 
5    Yes  No Yes  No Yes  No Yes  No Yes  No 
6    Yes  No Yes  No Yes  No Yes  No Yes  No 
7    Yes  No Yes  No Yes  No Yes  No Yes  No 
8    Yes  No Yes  No Yes  No Yes  No Yes  No 
9    Yes  No Yes  No Yes  No Yes  No Yes  No 
10    Yes  No Yes  No Yes  No Yes  No Yes  No 
11    Yes  No Yes  No Yes  No Yes  No Yes  No 
12    Yes  No Yes  No Yes  No Yes  No Yes  No 
13    Yes  No Yes  No Yes  No Yes  No Yes  No 
14    Yes  No Yes  No Yes  No Yes  No Yes  No 
15    Yes  No Yes  No Yes  No Yes  No Yes  No 
16    Yes  No Yes  No Yes  No Yes  No Yes  No 
17    Yes  No Yes  No Yes  No Yes  No Yes  No 
18    Yes  No Yes  No Yes  No Yes  No Yes  No 
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19    Yes  No Yes  No Yes  No Yes  No Yes  No 
20    Yes  No Yes  No Yes  No Yes  No Yes  No 
21    Yes  No Yes  No Yes  No Yes  No Yes  No 
22    Yes  No Yes  No Yes  No Yes  No Yes  No 
23    Yes  No Yes  No Yes  No Yes  No Yes  No 
24    Yes  No Yes  No Yes  No Yes  No Yes  No 
25    Yes  No Yes  No Yes  No Yes  No Yes  No 
26    Yes  No Yes  No Yes  No Yes  No Yes  No 
27    Yes  No Yes  No Yes  No Yes  No Yes  No 
28    Yes  No Yes  No Yes  No Yes  No Yes  No 
29    Yes  No Yes  No Yes  No Yes  No Yes  No 
30    Yes  No Yes  No Yes  No Yes  No Yes  No 
31    Yes  No Yes  No Yes  No Yes  No Yes  No 
32    Yes  No Yes  No Yes  No Yes  No Yes  No 
33    Yes  No Yes  No Yes  No Yes  No Yes  No 
34    Yes  No Yes  No Yes  No Yes  No Yes  No 
35    Yes  No Yes  No Yes  No Yes  No Yes  No 
36    Yes  No Yes  No Yes  No Yes  No Yes  No 
37    Yes  No Yes  No Yes  No Yes  No Yes  No 
38    Yes  No Yes  No Yes  No Yes  No Yes  No 
39    Yes  No Yes  No Yes  No Yes  No Yes  No 
40    Yes  No Yes  No Yes  No Yes  No Yes  No 
 Total 
#/#days 
___________ 
Total 
#/#days 
___________ 
Total 
#/#days 
___________ 
Total Yes/No 
_____/_____ 
Total Yes/No 
_____/_____ 
Total Yes/No 
_____/_____ 
Total Yes/No 
_____/_____ 
 
 Mean 
___________ 
Mean 
___________ 
Mean 
__________ 
% yes  
______ 
% yes  
______ 
% yes  
______ 
% yes  
______ 
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Appendix E. APACHE II Severity of Disease Classification System 
 
 
 
 
 
 
 
 
The appendices must adhere to the same margin specifications as the body of the doctoral project. Photocopied or previously  
 
 
 
 
 
From “Apache II: A Severity of Disease Classification System” by W. Knaus, E. Draper, D. Wagner and J. Zimmerman 
(1985), Critical Care Medicine, Volume 13(10), pp. 818-829. Copyright 1986 by Wolters Kluwer Health. Reprinted with permission.
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Appendix F. Permission to use APACHE II Severity of Disease Classification System 
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Appendix G. Poster Presentation of Project 
 
